| Aug 7 |
Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
|
| Jul 9 |
Cantor sees Tango benefitting from Ideaya's positive data
|
| Jul 9 |
Expert Outlook: Tango Therapeutics Through The Eyes Of 6 Analysts
|
| Jun 5 |
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
|
| May 23 |
Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program
|
| May 23 |
Tango Therapeutics to discontinue development of TNG348 program
|
| May 23 |
Tango Therapeutics Announces Discontinuation of TNG348 Program
|
